Looking for the name of Marcel Proust on search engines, it seems that the centenary of his death (1922) has gone unnoticed by medical doctors. Several essays on his illness have already been ...

Last year, a puzzling case caught the attention of Dr. Mary Lee-Wong at Maimonides Medical Center. An elderly patient with both asthma and chronic obstructive pulmonary disease had shown no signs of ...

Tectonic Therapeutic, Inc.'s stock surged 120% on positive Phase 1b data for TX45 in treating PH-HFpEF, offering a potential ...

During and after an exacerbation, mental recovery involves taking care of both your physical and mental health. Resting, ...

Merck said the Phase 3 "Hyperion" study, which was evaluating Winrevair versus placebo in recently diagnosed adults with PAH at intermediate or high risk of disease progression, had lost clinical ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide (Wegovy and Ozempic) and tirzepatide (Mounjaro) may ...

All patients in the trial will have the opportunity to resume or begin treatment with Winrevair, the company said.

Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, and often fatal lung disease characterized by the scarring (fibrosis) of lung tissue, ...

In a world where respiratory issues are increasingly common, finding practical solutions can be daunting. Breathe Drops ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

The pulmonary fibrosis market is driven by the increasing prevalence of pulmonary fibrosis, especially idiopathic pulmonary fibrosis (IPF), among the aging population, which boosts demand for ...

Having finally won US marketing approval, Cyclopharm has signed up the nation's biggest private and public hospital groups.